People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Healthtech, Medical Devices, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Saluda Medical, Inc. | — | Healthtech | Series D+ | $180.0M | $232.2M | 2023 |
| Zenflow, Inc. | — | Medical Devices | Series B | $75.3M | $116.6M | 2021 |
| Francis Medical, Inc. | — | Healthtech | Series B | $70.1M | $233.8M | 2024 |
| Velomedix, Inc. | — | Biotechnology | Series A | $27.3M | $335.9M | 2010 |
| Sympara Medical, Inc. | — | Other | Series A | $12.8M | $45.6M | 2014 |
Andrew Cleeland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Cleeland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Weisskoff | 1 | 12 |
| Daniel Burnett | 1 | 11 |
| Juliet Bakker | 1 | 9 |
| Jan Garfinkle | 1 | 7 |
| Ross Jaffe | 1 | 7 |
| David Adair | 1 | 7 |
| Juan-Pablo Mas | 1 | 5 |
| J. Casey McGlynn | 1 | 5 |
| John Dean | 1 | 5 |
| Michael Hoey | 1 | 4 |
| Bryan Kim | 1 | 4 |
| Uday N. Kumar | 1 | 3 |
| Casey McGlynn | 1 | 3 |
| John Beck | 1 | 3 |
| Doug Godshall | 1 | 3 |
| Ken Ludlum | 1 | 3 |
| Robert Palmisano | 1 | 3 |
| Geoffrey Brooke | 1 | 2 |
| Andre De Bruin | 1 | 2 |
| Marc Galletti | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.